Lindbrook Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$10.8K Buy
874
+197
+29% +$2.79K ﹤0.01% 1614
2024
Q4
$9.38K Buy
677
+574
+557% +$9.05K ﹤0.01% 1687
2024
Q3
$1.72K Sell
103
-758
-88% -$16.3K ﹤0.01% 2395
2024
Q2
$17.8K Buy
861
+720
+511% +$15.6K ﹤0.01% 1312
2024
Q1
$3.49K Buy
141
+97
+220% +$2.89K ﹤0.01% 2050
2023
Q4
$1.6K Buy
44
+28
+175% +$1.08K ﹤0.01% 2334
2023
Q3
$772 Sell
16
-6
-27% -$356 ﹤0.01% 2432
2023
Q2
$1.5K Buy
22
+6
+38% +$387 ﹤0.01% 2260
2023
Q1
$776 Sell
16
-26
-62% -$1.37K ﹤0.01% 2510
2022
Q4
$2.53K Buy
42
+4
+11% +$234 ﹤0.01% 2129
2022
Q3
$2K Buy
+38
New +$1.2K ﹤0.01% 2119

Other funds holding PRTA

Lindbrook Capital's PRTA Position: Q1 2025 in Review

Lindbrook Capital increased its Prothena Corp (PRTA) stake by 29% in Q1 2025, buying an estimated $2.79K and bringing the position to 874 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

Lindbrook Capital first reported a position in PRTA in Q3 2022 and has held it in 11 quarters since. The position peaked at $17.8K in Q2 2024. 161 funds tracked by Wall St. Rank hold PRTA as of Q1 2025.

  • Lindbrook Capital held 874 shares of Prothena Corp worth $10.8K as of Q1 2025.
  • Lindbrook Capital bought 197 Prothena Corp shares in Q1 2025, an estimated $2.79K.
  • Prothena Corp made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1614 holding.
  • Lindbrook Capital first reported a position in Prothena Corp in Q3 2022 and has held it in 11 quarters since.
  • Lindbrook Capital's Prothena Corp position peaked at $17.8K in Q2 2024.
  • 161 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.